BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBX3 | Chromobox homolog 3 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT2 | Chaperonin containing TCP1, subunit 2 (beta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT8 | Chaperonin containing TCP1, subunit 8 (theta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD93 | CD93 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC7 | Cell division cycle 7 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDV3 | CDV3 homolog (mouse) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CELF1 | CUGBP, Elav-like family member 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CFL1 | Cofilin 1 (non-muscle) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLINT1 | Clathrin interactor 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLTA | Clathrin, light chain A | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CMAS | Cytidine monophosphate N-acetylneuraminic acid synthetase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |